(VIANEWS) – KITRON (KIT.OL), ELIS (ELIS.PA), NORBIT (NORBT.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. KITRON (KIT.OL)
1046.9% sales growth and 22.67% return on equity
Kitron ASA operates as an electronics manufacturing services company in Norway, Sweden, Denmark, Lithuania, Germany, Poland, the Czech Republic, India, China, Malaysia, and the United States. It manufactures and sells electronics that are embedded in the customer's own products; and box-built electronic products. The company's services include development services, such as product development, product management, and re-engineering services; and industrialization services, including prototype manufacturing, evaluation of new products, component engineering and database, test development, design and build of high-level assembly lines, and environmental durability testing. Its services comprise sourcing and procurement services; manufacturing, assembling, and testing of electronic products for the professional market; redesign, repair, and maintenance, as well as logistics and distribution, and product deployment services. The company markets its services to connectivity, electrification, industry, medical devices, and defence/aerospace sectors. Kitron ASA was incorporated in 1996 and is headquartered in Billingstad, Norway.
Earnings Per Share
As for profitability, KITRON has a trailing twelve months EPS of kr2.24.
PE Ratio
KITRON has a trailing twelve months price to earnings ratio of 13.83. Meaning, the purchaser of the share is investing kr13.83 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.67%.
Moving Average
KITRON’s value is way below its 50-day moving average of kr35.27 and under its 200-day moving average of kr33.26.
More news about KITRON.
2. ELIS (ELIS.PA)
77.2% sales growth and 7.22% return on equity
Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. It provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. The company was founded in 1883 and is headquartered in Saint-Cloud, France.
Earnings Per Share
As for profitability, ELIS has a trailing twelve months EPS of €1.06.
PE Ratio
ELIS has a trailing twelve months price to earnings ratio of 19.87. Meaning, the purchaser of the share is investing €19.87 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.22%.
More news about ELIS.
3. NORBIT (NORBT.OL)
35% sales growth and 22.97% return on equity
Norbit ASA provides technology products and solutions. It operates through Oceans, Connectivity, and Product Innovation and Realization segments. The company offers multibeam sonar systems, including integrated bathymetric systems, bathymetry systems, advanced monitoring systems for dredging, construction and renewables, forward looking wide area imaging, advanced imaging systems for obstacle avoidance/MCM, and above water laser products under the NORBIT WINGHEAD, NORBIT WBMS, NORBIT NORdredge, and NORBIT FLS names; customized cable assemblies, electromechanical box builds, and operational solutions; SeaCOP, a sensor integration platform and user interface common operational picture for emergency response; SECurus provides thermal and daylight stabilized camera solutions; SeaView, which offers thermal and daylight, pan, tilt, and zoom for environmental monitoring, and security and general surveillance; and SeaDarQ, a radar processing solution. It also provides sensing solutions for detecting threats at sea plus waterside security above and below the surface; FCL600, an underwater light solution for aquaculture industry; iData, which offers vehicle monitoring, telematics services, and fleet management for asset and vehicle management; and dedicated short-range communication technology for traffic system and vehicle application. In addition, the company offers research and development services, and contract manufacturing to industrial customers; and sells products based on proprietary technology, including special instrumentation n based on radar, radio frequency, and embedded signal processing technology. Norbit ASA was founded in 1995 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, NORBIT has a trailing twelve months EPS of kr2.77.
PE Ratio
NORBIT has a trailing twelve months price to earnings ratio of 31.34. Meaning, the purchaser of the share is investing kr31.34 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.97%.
Sales Growth
NORBIT’s sales growth is negative 3.5% for the present quarter and 35% for the next.
Volume
Today’s last reported volume for NORBIT is 46989 which is 61.81% below its average volume of 123050.
More news about NORBIT.
4. BOUVET (BOUV.OL)
9.7% sales growth and 60.9% return on equity
Bouvet ASA provides IT and digital communication consultancy services for public and private sector companies in Norway, Sweden, and internationally. The company was incorporated in 1995 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, BOUVET has a trailing twelve months EPS of kr3.48.
PE Ratio
BOUVET has a trailing twelve months price to earnings ratio of 19.83. Meaning, the purchaser of the share is investing kr19.83 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.9%.
More news about BOUVET.
5. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Sales Growth
SANOFI’s sales growth for the next quarter is 7.4%.
Moving Average
SANOFI’s worth is below its 50-day moving average of €97.73 and below its 200-day moving average of €91.63.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 13, 2024, the estimated forward annual dividend rate is 3.76 and the estimated forward annual dividend yield is 3.64%.
More news about SANOFI.
6. SPIE (SPIE.PA)
7.3% sales growth and 11.6% return on equity
SPIE SA provides multi-technical services in the areas of energy and communications in France, Germany, the Netherlands, and internationally. The company operates through four segments: France; Germany and Central Europe; North-Western Europe; and Oil & Gas and Nuclear. It provides building modelling and design services; IT maintenance and managed services; information and communications technology engineering and consulting services; technical facility management, energy-efficiency, and technical services for the transmission and distribution of energy for industrial clients, as well as in the areas of electrical and security, HVAC, and information and communications technology; and electrical, mechanical, and HVAC engineering services. The company also offers building information modelling, building management systems, augmented reality, IoT and data management, and smart maintenance services; oil and gas services; construction, renovation, and maintenance services for bridges, locks, and pumping stations; maintenance and innovative solutions for traffic infrastructure; and fixed and mobile digital telecom networks, as well as technical building management, communications and networks, and tech FM services; engineering, construction, maintenance, and optimization services for industrial processes; energy recovery and sustainable management services to technical facilities; and energy transmission networks, medium-voltage facilities, distribution networks, busbar systems, and wind and solar power farms. In addition, it engages in the analysis of site conditions; planning, installation, and commissioning of technology; mechanical and industrial robotic solutions; and provision of electric solutions comprising lighting, street lighting, safety and security, prefabrication, and signage solutions. SPIE SA was founded in 1900 and is headquartered in Cergy-Pontoise, France.
Earnings Per Share
As for profitability, SPIE has a trailing twelve months EPS of €1.44.
PE Ratio
SPIE has a trailing twelve months price to earnings ratio of 24.18. Meaning, the purchaser of the share is investing €24.18 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.6%.
Volume
Today’s last reported volume for SPIE is 186455 which is 11.89% below its average volume of 211627.
Yearly Top and Bottom Value
SPIE’s stock is valued at €34.82 at 22:20 EST, under its 52-week high of €38.60 and way higher than its 52-week low of €23.84.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 9.34B for the twelve trailing months.
Moving Average
SPIE’s worth is below its 50-day moving average of €35.26 and above its 200-day moving average of €33.38.
More news about SPIE.
